(Q46028169)

English

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.

scientific article published on 4 May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

0 references

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

author name string

Judith Del Campo

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Caridad Zayas

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Belkis Romeu

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Reinaldo Acevedo

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Elizabeth González

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Gustavo Bracho

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Maribel Cuello

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Osmir Cabrera

8

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Julio Balboa

9

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Miriam Lastre

10

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

language of work or name

1 reference

based on heuristic

inferred from title

publication date

4 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

49

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

301-308

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

Mucosal vaccines: the promise and the challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Perspectives on mucosal vaccines: is mucosal tolerance a barrier?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

The role of nasopharyngeal lymphoid tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Systemic and mucosal immunity induced by BCG vector expressing outer-surface protein A of Borrelia burgdorferi

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Mucosal immunity and gastrointestinal antigen processing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

New vaccines require potent adjuvants like AFPL1 and AFCo1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Validation of colorimetric assay to detect complement-mediated antibody-dependent bactericidal activity against serogroups B and C Neisseria meningitidis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Mucosal immunity and vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Immunomodulators and delivery systems for vaccination by mucosal routes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Interaction of antigens and antibodies at mucosal surfaces

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

A protective role of locally administered immunostimulatory CpG oligodeoxynucleotide in a mouse model of genital herpes infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Intranasal administration of recombinant Neisseria gonorrhoeae transferrin binding proteins A and B conjugated to the cholera toxin B subunit induces systemic and vaginal antibodies in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YMETH.2009.03.025

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/19410000

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46028169&oldid=1635240681"